A specific antidote for dabigatran: functional and structural characterizationFelix Schiele, Tobias Litzenburger, Joanne van Ryn et al.|Blood|2013Cited by 562
An Antibody against the C-Terminal Domain of PCSK9 Lowers LDL Cholesterol Levels In VivoFelix Schiele, Herbert Nar, John Park et al.|Journal of Molecular Biology|2013Cited by 35
Structure-guided residence time optimization of a dabigatran reversal agentFelix Schiele, Herbert Nar, Joanne van Ryn et al.|mAbs|2015Cited by 14
Solution structure and synaptic analyses reveal determinants of bispecific T cell engager potencyAlexander Leithner, Michael L. Dustin, J.‐M. Spaeth et al.|Proceedings of the National Academy of Sciences|2025Cited by 12
Anti-GARP Antibodies Inhibit Release of TGF-β by Regulatory T Cells via Different Modes of Action, but Do Not Influence Their Function In VitroFrederik H. Igney, Herbert Nar, Rebecca Ebenhoch et al.|ImmunoHorizons|2023Cited by 6